Evidence map›Paper›PMID 14569247›Full record

ArticleJournal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology

First annual Mario S. Verani, MD, Memorial lecture: clinical value of myocardial perfusion imaging in coronary artery disease.

George A Beller

2 registry-linked trialsAbstract readLecture
PubMed Publisher
In one paragraph

Article in Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00849108 phase2completednot on this map

A Phase 2, Open-Label, Randomized Multicenter Study for the Development of One-Day Rest/Stress Cardiac Positron Emission Tomography (PET) Perfusion Imaging Protocols of BMS747158

TypeinterventionalSponsorLantheus Medical ImagingRan2009 to 2010Enrolled176ConditionsIschemiaArmsBMS747158
NCT01085162 withdrawnnot on this map

An Open-Label Prospective, Non-Randomized, International, Multi-center, Long-term Follow-up Study to Evaluate the Predictive Value of BMS747158 Positron Emission Tomography (PET) Myocardial Perfusion Imaging (MPI) in Patients Suspected of Coronary Artery Disease (CAD)

TypeobservationalSponsorLantheus Medical ImagingRan2013 to 2015Enrolled0ConditionsCoronary Artery Disease (CAD)ArmsBMS747158
3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 32 citations in OpenAlex.

  1. Mechanical dyssynchrony: How do we measure it, what it means, and what we can do about it.Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2021
    Article
  2. The prognostic value of diastolic and systolic mechanical left ventricular dyssynchrony among patients with coronary artery disease and heart failure.Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2020
    Article
  3. Article
  4. An alternative method to examine the predictive value of mechanical dyssynchrony.Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2015
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Second Annual Mario S. Verani, MD, Memorial Lecture: Nuclear cardiology, the next 10 years.Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology
    Article
  11. Myocardial perfusion imaging with adenosine triphosphate predicts the rate of cardiovascular events.Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

George A BellerDepartment of Medicine, University of Virginia Health System, Charlottesville, VA 22908, USA. gbeller@virginia.edu
University of Virginia Health System · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

I am honored to give this lecture in memory of Dr Mario S. Verani, a friend and a respected colleague in the field of nuclear cardiology. Dr Verani made many immense contributions to the field of nuclear cardiology during his lifetime. He was a pioneer in the field of pharmacologic stress imaging and played a leading role in validating the utility of intravenous adenosine infusion for stress imaging in detecting significant coronary stenoses and assessing prognosis. He and his colleagues at Baylor reported that pharmacologic stress imaging could separate high- and low-risk patient subsets after acute myocardial infarction, particularly among patients who underwent thrombolytic therapy. He informed us that certain drugs that patients took could influence perfusion defect severity. This work led to a clinical study showing that ischemic defect size could be substantially reduced with medical therapy in patients who had recently had an acute infarction. An outcome of this observation was the launching of the INSPIRE (adenosINe technetium-99m Sestamibi single-photon emission computed tomography Post-InfaRction Evaluation) trial in which postinfarction patients are randomized to medical therapy or revascularization. Dr Verani was an able debater when assigned the position for advocating for stress radionuclide perfusion imaging against stress echocardiography. He engaged in these debates with substantial knowledge but always with a touch of humor. Dr Verani's courage was an inspiration to all of us during his illness. His legacy as a pioneer will endure as the field of nuclear cardiology continues to mature and expand.

Indexed as

Coronary Artery DiseaseCoronary CirculationCoronary VesselsCost-Benefit AnalysisGated Blood-Pool ImagingHeartHumansPractice Patterns, Physicians'Predictive Value of TestsPrognosisRisk AssessmentTissue SurvivalVentricular Dysfunction, Left

Identifiers

PMID14569247
OpenAlexW1998611028

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.